KnowU and UBand Bio-RFID non-invasive blood glucose monitors target painful finger-sticking eradication

 

The KnowU and UBand Bio-RFID non-invasive blood glucose monitors are currently under further testing by the company that designed them, Know Labs (Visulant, Incorporated).

Charts produced by Know Labs compare its Bio-RFID technology with the Accu-Check Fingerstick, FreeStyle Libre 14-day, and Dexcom G6, which all rely on minimally invasive/invasive methods to produce blood glucose level readings.

While the two devices are still in a pre-FDA study stage, recent comparison tests published by the company have shined a promising light on the KnowU and UBand. Both monitors utilize radio-frequency identification (RFID) to collect the required data for blood sugar level management.

There has been mention of the KnowU and UBand potentially progressing onto the FDA approval stage at some point in 2022, which means painful finger-sticking could be consigned to history’s bin within a couple of years.